Azitra, INC. (AZTR) — 10-Q Filings

10-Q Filings (6)

• Azitra's Losses Mount, Cash Dwindles Amid NYSE Delisting Threat — Nov 12, 2025 Risk: high
  Azitra, Inc. (AZTR) reported a significant net loss of $2,764,528 for the three months ended September 30, 2025, an increase from a net loss of $1,009,491 in th
• Azitra's Q2 Net Loss Widens to $6.03M Amid R&D Spend — Aug 11, 2025 Risk: high
  Azitra, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company's net loss for the three
• Azitra, Inc. Files Q1 2025 10-Q — May 13, 2025 Risk: medium
  Azitra, Inc. filed its 10-Q for the period ending March 31, 2025. The company's primary focus is on the development of novel treatments for respiratory diseases
• Azitra, Inc. Files Q3 2024 10-Q Report — Nov 12, 2024 Risk: low
  Azitra, Inc. filed its 10-Q for the period ending September 30, 2024. The company's fiscal year ends on December 31st. The filing was made on November 12, 2024,
• Azitra, Inc. Files 10-Q for Q2 2024 — Aug 12, 2024 Risk: medium
  Azitra, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business operations. Spe
• Azitra, Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
  Azitra, Inc. (AZTR) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Azitra, Inc. filed a 10-Q report for the period ending March 31, 2024. The comp

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX